Pre-market
Loading markets…

Advertisement

Stocks

Why Kane Biotech Inc stock surged yesterday

By Wealth Awesome -

This move is archived. Current quotes and coverage live on the stock page.

Stocks & ETFs:KNE.V

Follow KNE

Photos provided by Pexels

Kane Biotech Inc experienced a remarkable surge in stock value, closing up 50% in yesterday's trading session.

Kane Biotech Inc (KNE.V) saw its stock price soar by 50% yesterday, closing at CA$0.03. This impressive gain marks a significant shift for the small-cap biotech firm, which has been working to expand its market presence in Canada.

Investor takeaway: Investors should monitor Kane Biotech's ongoing developments, as the recent surge may indicate growing market confidence in the company's strategic initiatives.

Advertisement

Kane Biotech Inc

KNE.V

Full stock page →

KNE.V

Kane Biotech Inc

Source:WealthAwesomeWealthAwesome
↓ $0.01 (-14.29%)
120 day period
$0.02$0.03$0.04Mar 11Jun 26Oct 21

Market cap

$6.15M

52W high

$0.05

52W low

$0.02

1W change

+20.00%

Beta

0.24

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on KNE's historical volatility

HistoricalForecast68%95%
C$0.00C$0.09C$0.17C$0.25C$0.33C$0.42TodayMay 7Jul 28Oct 21Dec 3Jan 16Feb 28

30-Day Vol

217.7%

Annualized

90-Day Vol

189.0%

Annualized

Trend (90d)

+0.0%

Annualized drift

90d Mean

C$0.03

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$0.03C$0.01 – C$0.06
60 trading daysC$0.03C$0.01 – C$0.09
90 trading daysC$0.03C$0.01 – C$0.11

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

Advertisement

Bull case

The recent partnership with Ontario Medical Supply Inc. could boost Kane Biotech's distribution capabilities, leading to increased revenue and market share. This collaboration might help the company reach more customers and enhance its presence in the Canadian market.

Bear case

Despite the surge, Kane Biotech's financial metrics raise concerns. With a market cap of only CA$6.15 million and no profit margin reported, potential investors should be cautious. These factors bring up questions about the company's long-term sustainability and ability to maintain this growth.

Advertisement

Advertisement

Wealth Awesome
Written by

Wealth Awesome

Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.

View Full Profile →

✅ Reviewed by Certified Financial Professionals

This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.

Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.

📊 Data AccuracyVerified sources
🇨🇦 Canadian FocusLocal expertise
🔍 Fact-CheckedEditorial review

⚠️ Professional Disclaimer

This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.

Published: September 10, 2026
Last Updated: September 23, 2026

Core portfolio

Awesome Portfolio™

14.8% a year since 2017, against 9.7% for the S&P/TSX Composite. Ten stocks, easy to manage. We update it once a month.

Annualized

+14.8%

Awesome Portfolio™

+9.7%

S&P/TSX

+5.0 pp better a year

Total return

+254%

Awesome Portfolio™

+134%

S&P/TSX

+119 pp better than the TSX

2017-07-31 to 2026-09-29, dividends reinvested, before fees and tax.

Awesome Portfolio™S&P/TSX CompositeCumulative return · 2017-07-31–2026-09-29
-11.7%42.5%96.7%150.9%205.1%259.3%Jul 17Oct 19Feb 22Jun 24Sep 26

Sponsored links

Advertisement